Skip to main content
. Author manuscript; available in PMC: 2014 Nov 16.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Sep 8;(9):CD007396. doi: 10.1002/14651858.CD007396.pub2
Methods RCT, 2-arm parallel groups.
Participants Hospital setting.
199 women: in labour, at term gestation, following normal pregnancy
No inclusion or exclusion criteria reported.
Interventions Experimental: IM pentazocine 20-40 mg (N = 91).
Control: IM pethidine 50-100mg(N= 89).
Outcomes Primary: analgesic and sedative effects. Pain assessed at time of birth or when second injection administered, as very good, good, moderate or none
Secondary: maternal and neonatal side effects.
Notes If additional analgesia required opioid repeated once after 3 or > hrs of first injection. Actual dose received by women not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Ampoules numbered and in random order.
Blinding (performance bias and detection bias)
Women
Unclear risk Reported as double blind, but no description of how achieved. Identical volume but appearance not described
Blinding (performance bias and detection bias)
Clinical staff
Unclear risk Reported as double blind, but no description of how achieved. Identical volume but appearance not described
Blinding (performance bias and detection bias)
Outcome assessor
Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants analysed, but missing data for some outcomes
Selective reporting (reporting bias) Unclear risk Unclear.
Other bias Low risk Balanced at baseline for age, parity, blood pressure, pulse, frequency contractions, FHR, augmented labour, intensity of labour, membranes intact or ruptured